{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T12:48:22Z","timestamp":1769345302832,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.neurol.2021.07.018","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T09:04:40Z","timestamp":1634288680000},"page":"337-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune cerebellar hypermetabolism: Report of three cases and literature overview"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-0788","authenticated-orcid":false,"given":"J.-B.","family":"Brunet de Courssou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Castilla-Lievre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6410-2856","authenticated-orcid":false,"given":"J.","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-0041","authenticated-orcid":false,"given":"M.-L.","family":"Brechemier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ohlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sallansonnet-Froment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tafani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Psimaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ricard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bompaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-963X","authenticated-orcid":false,"given":"I.","family":"Taifas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2021.07.018_bib0255","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0260","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00262-019-02310-2","article-title":"Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors","volume":"68","author":"Nadal","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.neurol.2021.07.018_bib0265","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/WCO.0000000000000503","article-title":"Neurological toxicities associated with immune checkpoint inhibitors","volume":"30","author":"Touat","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0270","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1212\/NXI.0000000000000604","article-title":"Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors","volume":"6","author":"Vogrig","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.neurol.2021.07.018_bib0275","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00281-016-0595-8","article-title":"Cancer immunotherapy in patients with preexisting autoimmune disorders","volume":"39","author":"Donia","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0280","first-page":"215","volume":"vol. 103","author":"Vernino","year":"2012"},{"key":"10.1016\/j.neurol.2021.07.018_bib0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1570159X16666180917105033","article-title":"Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges","volume":"17","author":"Mitoma","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0290","first-page":"313","volume":"vol. 155","author":"Joubert","year":"2018"},{"key":"10.1016\/j.neurol.2021.07.018_bib0295","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurol.2010.07.032","article-title":"Clinical presentation of immune-mediated cerebellar ataxia","volume":"167","author":"Demarquay","year":"2011","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0300","first-page":"85","volume":"vol. 103","author":"Mascalchi","year":"2012"},{"key":"10.1016\/j.neurol.2021.07.018_bib0305","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/RLU.0b013e3182478bf2","article-title":"Apparent relative hypermetabolism of selective brain areas in huntington disease and importance of reference region for analysis","volume":"37","author":"Lee","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0310","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/RLU.0b013e3181e05dbc","article-title":"Hypermetabolism in patients with dementia with Lewy bodies","volume":"35","author":"Miyazawa","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.10.020","article-title":"Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns","volume":"87","author":"Ye","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2021.07.018_bib0320","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/RLU.0b013e31821a2604","article-title":"Cerebral hypermetabolism demonstrated by FDG PET in familial Creutzfeldt-Jakob disease","volume":"36","author":"Nagasaka","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0325","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/mds.28217","article-title":"Multicenter validation of metabolic abnormalities related to PSP according to the MDS-PSP criteria","volume":"35","author":"Mart\u00ed-Andr\u00e9s","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2021.07.018_bib0330","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00259-019-04570-7","article-title":"Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts","volume":"47","author":"Meles","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.neurol.2021.07.018_bib0335","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1111\/ene.14478","article-title":"COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography\/computed tomography findings","volume":"27","author":"Delorme","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0340","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.2967\/jnumed.120.249292","article-title":"Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from 18 F-FDG PET imaging and neuronal autoantibodies","volume":"61","author":"Grimaldi","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0345","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00003072-199703000-00018","article-title":"Contralateral cerebellar activation in frontal lobe epilepsy detected by ictal Tc-99m HMPAO brain SPECT","volume":"22","author":"Seto","year":"1997","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0350","first-page":"4","article-title":"Crossed cerebellar glucose hypermetabolism demonstrated using PET in symptomatic epilepsy in case report","volume":"19","author":"Kawanishit","year":"2005","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0355","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jocn.2008.07.073","article-title":"Crossed cerebellar hyperperfusion on ictal FDG PET in astrocytoma","volume":"16","author":"Lin","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.neurol.2021.07.018_bib0360","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/RLU.0b013e3180537621","article-title":"Cerebellar vermis relative hypermetabolism: an almost constant PET finding in an injured brain","volume":"32","author":"Lupi","year":"2007","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0365","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1874471007666140411103819","article-title":"18FDG-PET\/CT in traumatic brain injury patients: the relative hypermetabolism of vermis cerebelli as a medium and long-term predictor of outcome","volume":"7","author":"Lupi","year":"2014","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.neurol.2021.07.018_bib0370","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/diagnostics10060356","article-title":"18F-FDG-PET imaging patterns in autoimmune encephalitis: impact of image analysis on the results","volume":"10","author":"Moreno-Ajona","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.neurol.2021.07.018_bib0375","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1212\/NXI.0000000000000352","article-title":"Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis","volume":"4","author":"Probasco","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2021.07.018_bib0380","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/RLU.0b013e3182815f28","article-title":"Semiquantitative analysis of brain metabolism in patients with paraneoplastic neurologic syndromes","volume":"38","author":"Clapp","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0385","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","article-title":"Paraneoplastic cerebellar degeneration","volume":"42","author":"Peterson","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2021.07.018_bib0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psym.2019.08.007","article-title":"A metabolic brain pattern associated with anti-N-Methyl-D-aspartate receptor encephalitis","volume":"61","author":"Kerik-Rotenberg","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neurol.2021.07.018_bib0395","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2377-14-136","article-title":"Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography","volume":"14","author":"Wegner","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0400","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fneur.2018.00841","article-title":"Detection methods for autoantibodies in suspected autoimmune encephalitis","volume":"9","author":"Ricken","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0405","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00415-016-8389-4","article-title":"Longitudinal multi-modal neuroimaging in opsoclonus\u2013myoclonus syndrome","volume":"264","author":"Oh","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0410","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.braindev.2015.10.013","article-title":"Cerebral 18FluoroDeoxy-Glucose positron emission tomography in paediatric anti N-methyl-d-aspartate receptor encephalitis: a case series","volume":"38","author":"Lagarde","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.neurol.2021.07.018_bib0415","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2967\/jnumed.116.184333","article-title":"Diagnostic value of 18 F-FDG PET\/CT versus MRI in the setting of antibody-specific autoimmune encephalitis","volume":"58","author":"Solnes","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0420","first-page":"31","article-title":"Encore un syndrome d\u2019apn\u00e9es obstructives du sommeil\u00a0?","volume":"12","author":"Brunet de Courssou","year":"2021","journal-title":"Prat Neurol FMC"},{"key":"10.1016\/j.neurol.2021.07.018_bib0425","first-page":"253","article-title":"Atteinte c\u00e9r\u00e9belleuse d\u2019origine auto-immune\u00a0: \u00e0 propos de deux cas avec hyperm\u00e9tabolisme c\u00e9r\u00e9belleux","volume":"11","author":"Brunet de Courssou","year":"2020","journal-title":"Prat Neurol FMC"},{"key":"10.1016\/j.neurol.2021.07.018_bib0430","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1097\/RLU.0000000000001046","article-title":"18F-FDG PET\/CT brain imaging on a patient with paraneoplastic opsoclonus-myoclonus syndrome arising out of a mature cystic teratoma","volume":"41","author":"Na","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0435","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1212\/NXI.0000000000000168","article-title":"Cerebellar vermis hypermetabolism in opsoclonus-myoclonus without onconeural antibodies","volume":"2","author":"Legouy","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.neurol.2021.07.018_bib0440","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/MNM.0000000000000163","article-title":"Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings","volume":"35","author":"Masangkay","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.neurol.2021.07.018_bib0445","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jnnp.2005.075325","article-title":"Cerebellar hypermetabolism in paraneoplastic cerebellar degeneration","volume":"77","author":"Choi","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2021.07.018_bib0450","first-page":"79","article-title":"Cerebellar hypermetabolism on 18F-FDG PET\/CT with normal MRI in a case of paraneoplastic cerebellar degeneration with negative antibodies","volume":"34","author":"Sharma","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0455","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0972-3919.125781","article-title":"Isolated cerebellar hypermetabolism on FDG PET in a case of remitted primary breast lymphoma","volume":"29","author":"Mittal","year":"2014","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0460","doi-asserted-by":"crossref","first-page":"e10717","DOI":"10.1097\/MD.0000000000010717","article-title":"Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: case report","volume":"97","author":"Abdulaziz","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.neurol.2021.07.018_bib0465","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jns.2014.05.030","article-title":"Paraneoplastic downbeat nystagmus associated with cerebellar hypermetabolism especially in the nodulus","volume":"343","author":"Choi","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2021.07.018_bib0470","first-page":"165","article-title":"FDG-PET hypermetabolism in paraneoplastic cerebellar degeneration","volume":"111","author":"Castelnovo","year":"2011","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.neurol.2021.07.018_bib0475","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/RLU.0000000000002657","article-title":"Cerebellar hypermetabolism in a case of paraneoplastic cerebellar syndrome with the primary lymphoepithelial carcinoma in tonsil","volume":"44","author":"Wang","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.neurol.2021.07.018_bib0480","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2011-301969","article-title":"Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease","volume":"83","author":"Leypoldt","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2021.07.018_bib0485","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","article-title":"Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types","volume":"260","author":"Baumgartner","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0490","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.20614","article-title":"Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma","volume":"58","author":"Vitaliani","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2021.07.018_bib0495","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/brain\/awh526","article-title":"Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates","volume":"128","author":"Ances","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2021.07.018_bib0500","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1212\/NXI.0000000000000413","article-title":"Decreased occipital lobe metabolism by FDG-PET\/CT: an anti-NMDA receptor encephalitis biomarker","volume":"5","author":"Probasco","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721007013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721007013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:44:16Z","timestamp":1758519856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378721007013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0035378721007013"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2021.07.018","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune cerebellar hypermetabolism: Report of three cases and literature overview","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2021.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}